Evidence map›Paper›PMID 32565866›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2020

Effect of

Lizong Zhang, Jiali Lang, Lu Jin, Lushuai Jin, Beibei Cao, Xia Shao, Mingsun Fang, Yueqin Cai, Xia Liu, Huiying Fu and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. The Protective Effect ofFrontiers in pharmacology · 2021
    Article
  6. Article
  7. Frontiers in pharmacology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Lizong ZhangThe Second Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou 310053, China.
Jiali LangThe Second Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou 310053, China.
Lu JinThe Second Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou 310053, China.
Lushuai JinThe Second Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou 310053, China.
Beibei CaoThe Second Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou 310053, China.
Xia ShaoDepartment of Breast Surgery, Huzhou Central Hospital, Huzhou 313003, China.
Mingsun FangInstitute of Comparative Medicine, Zhejiang Chinese Medical University, Hangzhou, China.
Yueqin CaiInstitute of Comparative Medicine, Zhejiang Chinese Medical University, Hangzhou, China.
Xia LiuThe Second Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou 310053, China.ORCID https://orcid.org/0000-0002-9209-0562
Huiying FuThe Second Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou 310053, China.ORCID https://orcid.org/0000-0002-1782-5258
Qiyang ShouThe Second Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou 310053, China.ORCID https://orcid.org/0000-0003-1615-5309
Zhejiang Chinese Medical University · CNHuzhou Central Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Kidney-yang deficiency syndrome (KYDS) is a classic syndrome in traditional Chinese medicine, which is mainly caused by damage to the hypothalamic-pituitary-adrenal (HPA) axis.

Identifiers

PMID32565866
PMCPMC7256706
OpenAlexW3027539170

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.